SCHEMBL23910448

SCHEMBL23910448

CCOC(=O)C1=C(O)C(=O)N(Cc2ccc(F)cc2)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
ALDH1A1 P00352 3/20 0.58
CASP3 P42574 1/20 0.55
LIPG Q9Y5X9 4/20 0.50
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
PKM P14618 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
HTT P42858 2/20 0.43
POLB P06746 1/20 0.43
LMNA P02545 3/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
CCR6 P51684 1/20 0.42
HKDC1 Q2TB90 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PDE3B Q13370 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755307 0.87 CASP3 (0.70) MEN1KMT2AALDH1A1CASP3LIPG
SCHEMBL23918548 0.85 KMT2A (0.56) MEN1KMT2AALDH1A1CASP3MAPT
SCHEMBL24379688 0.82 ALDH1A1 (0.53) MEN1KMT2AALDH1A1CASP3POLB
SCHEMBL23918746 0.79 ALDH1A1 (0.55) MEN1KMT2AALDH1A1CASP3MAPT
SCHEMBL29428200 0.78 ALDH1A1 (0.48) MEN1KMT2AALDH1A1CASP3LIPG
SCHEMBL1534083 0.76 MEN1 (0.54) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL23918756 0.75 ALDH1A1 (0.51) MEN1KMT2AALDH1A1CASP3MAPT
SCHEMBL1839329 0.73 CASP3 (0.69) MEN1KMT2AALDH1A1CASP3MAPT
SCHEMBL4936795 0.73 MEN1 (0.43) MEN1KMT2AALDH1A1CASP3MAPT
SCHEMBL30604599 0.72 MEN1 (0.53) MEN1KMT2AALDH1A1CASP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111527090-B Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors 拜耳公司 2023-05-26 CN disclosed
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors BAYER AKTIENGESELLSCHAFT (DE) 2022-05-03 US disclosed
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors BAYER AKTIENGESELLSCHAFT (DE) 2022-05-03 US disclosed
EP-3700907-B1 NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS BAYER AG (DE) 2022-03-09 EP disclosed
US-20210317128-A1 NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed
US-20210317128-A1 NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2021-10-14 US disclosed
CN-111527090-A Novel pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors 拜耳公司 2020-08-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319324-B2 Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitors P2RX3, P2RX1, P2RX5 MEN1 2887/4885KMT2A 4618/4885ALDH1A1 1120/4885
US-20210317128-A1 NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS P2RX3, P2RX1, P2RX5 MEN1 3591/4885KMT2A 4670/4885ALDH1A1 1149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.